A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy
| Image |  |
|---|---|
| Description | scientific article published on 19 June 2020 |
| Author/s |
author: Study Alliance Leukemia (SAL) Richard Noppeney Jan-Henrik Mikesch Stefanie Göllner Carsten Müller-Tidow Martin Wermke Christoph Röllig Martin Dugas Caroline Pabst Uwe Platzbecker Martin Bornhäuser Maxi Wass Hubert Serve |
| Publication date | June 19, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |